110 related articles for article (PubMed ID: 8315481)
1. Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma.
Dimitrakopoulou A; Strauss LG; Clorius JH; Ostertag H; Schlag P; Heim M; Oberdorfer F; Helus F; Haberkorn U; van Kaick G
J Nucl Med; 1993 Jul; 34(7):1075-81. PubMed ID: 8315481
[TBL] [Abstract][Full Text] [Related]
2. Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma.
Dimitrakopoulou-Strauss A; Strauss LG; Schlag P; Hohenberger P; Möhler M; Oberdorfer F; van Kaick G
J Nucl Med; 1998 Jul; 39(7):1197-202. PubMed ID: 9669393
[TBL] [Abstract][Full Text] [Related]
3. Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma.
Dimitrakopoulou-Strauss A; Strauss LG; Schlag P; Hohenberger P; Irngartinger G; Oberdorfer F; Doll J; van Kaick G
J Nucl Med; 1998 Mar; 39(3):465-73. PubMed ID: 9529293
[TBL] [Abstract][Full Text] [Related]
4. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.
Moehler M; Dimitrakopoulou-Strauss A; Gutzler F; Raeth U; Strauss LG; Stremmel W
Cancer; 1998 Jul; 83(2):245-53. PubMed ID: 9669806
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma.
Kissel J; Brix G; Bellemann ME; Strauss LG; Dimitrakopoulou-Strauss A; Port R; Haberkorn U; Lorenz WJ
Cancer Res; 1997 Aug; 57(16):3415-23. PubMed ID: 9270007
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
Findlay M; Young H; Cunningham D; Iveson A; Cronin B; Hickish T; Pratt B; Husband J; Flower M; Ott R
J Clin Oncol; 1996 Mar; 14(3):700-8. PubMed ID: 8622014
[TBL] [Abstract][Full Text] [Related]
7. Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H2(15)O and [18F]uracil positron emission tomography (PET).
Hohenberger P; Strauss LG; Lehner B; Frohmüller S; Dimitrakopoulou A; Schlag P
Eur J Cancer; 1993; 29A(12):1682-6. PubMed ID: 8398294
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approach.
Kissel J; Port RE; Zaers J; Bellemann ME; Strauss LG; Haberkorn U; Brix G
Med Phys; 1999 Apr; 26(4):609-15. PubMed ID: 10227363
[TBL] [Abstract][Full Text] [Related]
9. Carbogen and nicotinamide increase blood flow and 5-fluorouracil delivery but not 5-fluorouracil retention in colorectal cancer metastases in patients.
Gupta N; Saleem A; Kötz B; Osman S; Aboagye EO; Phillips R; Vernon C; Wasan H; Jones T; Hoskin PJ; Price PM
Clin Cancer Res; 2006 May; 12(10):3115-23. PubMed ID: 16707610
[TBL] [Abstract][Full Text] [Related]
10. 18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases.
Zissen MH; Kunz P; Subbarayan M; Chin FT; Conti PS; Fisher GA; Quon A
Nucl Med Commun; 2011 May; 32(5):343-7. PubMed ID: 21412178
[TBL] [Abstract][Full Text] [Related]
11. Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium-DTPA-enhanced MRI and localized 19F MRS pharmacokinetic studies of 5-fluorouracil.
van Laarhoven HW; Klomp DW; Rijpkema M; Kamm YL; Wagener DJ; Barentsz JO; Punt CJ; Heerschap A
NMR Biomed; 2007 Apr; 20(2):128-40. PubMed ID: 17006886
[TBL] [Abstract][Full Text] [Related]
12. Blocking catabolism with eniluracil enhances PET studies of 5-[18F]fluorouracil pharmacokinetics.
Bading JR; Alauddin MM; Fissekis JD; Shahinian AH; Joung J; Spector T; Conti PS
J Nucl Med; 2000 Oct; 41(10):1714-24. PubMed ID: 11038003
[TBL] [Abstract][Full Text] [Related]
13. Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer.
Bender H; Bangard N; Metten N; Bangard M; Mezger J; Schomburg A; Biersack HJ
Hybridoma; 1999 Feb; 18(1):87-91. PubMed ID: 10211794
[TBL] [Abstract][Full Text] [Related]
14. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.
Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG
Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089
[TBL] [Abstract][Full Text] [Related]
15. [Positron emission tomography following brief infusion of 5-[18F]uracil: linear model for the kinetics of 18F radioactivity in tumors].
Port RE; Strauss LG; Clorius JH
Onkologie; 1989 Aug; 12 Suppl 1():51-2. PubMed ID: 2685698
[TBL] [Abstract][Full Text] [Related]
16. Vasopressin selectively increases 5-fluorouracil uptake by colorectal liver metastases following hepatic artery bolus infusion.
Dietz DW; Casillas S; Jones SC; Milsom JW
J Surg Res; 1998 Jul; 77(2):150-6. PubMed ID: 9733602
[TBL] [Abstract][Full Text] [Related]
17. Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data.
Chazal M; Cheradame S; Formento JL; Francoual M; Formento P; Etienne MC; François E; Richelme H; Mousseau M; Letoublon C; Pezet D; Cure H; Seitz JF; Milano G
Clin Cancer Res; 1997 Apr; 3(4):553-7. PubMed ID: 9815719
[TBL] [Abstract][Full Text] [Related]
18. Extraction of 5-fluorouracil by tumor and liver: a noninvasive positron emission tomography study of patients with gastrointestinal cancer.
Aboagye EO; Saleem A; Cunningham VJ; Osman S; Price PM
Cancer Res; 2001 Jul; 61(13):4937-41. PubMed ID: 11431319
[TBL] [Abstract][Full Text] [Related]
19. Drug monitoring of 5-fluorouracil: in vivo 19F NMR study during 5-FU chemotherapy in patients with metastases of colorectal adenocarcinoma.
Schlemmer HP; Bachert P; Semmler W; Hohenberger P; Schlag P; Lorenz WJ; van Kaick G
Magn Reson Imaging; 1994; 12(3):497-511. PubMed ID: 8007780
[TBL] [Abstract][Full Text] [Related]
20. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer].
Yamashita K; Urakami A; Kubota H; Nagatsuka R; Murakami H; Kawabe Y; Higashida M; Hirabayashi Y; Mikami Y; Ikeda M; Fuchimoto M; Yamamura M; Oka Y; Okumura H; Iki K; Matsumoto H; Imai S; Hirai T; Tsunoda T
Gan To Kagaku Ryoho; 2008 Jan; 35(1):71-6. PubMed ID: 18195531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
